1	c	c	_	_	_	_	_	_	_
2	-	-	_	_	_	_	_	_	_
3	Rel	Rel	_	_	_	_	_	_	_
4	is	be	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	target	target	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	pentoxifylline-mediated	pentoxifylline-mediated	_	_	_	_	_	_	_
9	inhibition	inhibition	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	T	t	_	_	_	_	_	_	_
12	lymphocyte	lymphocyte	_	_	_	_	_	_	_
13	activation	activation	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	possible	possible	_	_	_	_	_	_	_
3	clinical	clinical	_	_	_	_	_	_	_
4	use	use	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	methyl	methyl	_	_	_	_	_	_	_
8	xanthine	xanthine	_	_	_	_	_	_	_
9	derivative	derivative	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	pentoxifylline	pentoxifylline	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	PF	PF	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	for	for	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	treatment	treatment	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	T	t	_	_	_	_	_	_	_
21	cell-dependent	cell-dependent	_	_	_	_	_	_	_
22	diseases	disease	_	_	_	_	_	_	_
23	is	be	_	_	_	_	_	_	_
24	being	be	_	_	_	_	_	_	_
25	noted	note	_	_	_	_	_	_	_
26	with	with	_	_	_	_	_	_	_
27	increasing	increase	_	_	_	_	_	_	_
28	interest	interest	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	this	this	_	_	_	_	_	_	_
3	paper	paper	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	we	we	_	_	_	_	_	_	_
6	studied	study	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	molecular	molecular	_	_	_	_	_	_	_
9	consequences	consequence	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	PF	PF	_	_	_	_	_	_	_
12	treatment	treatment	_	_	_	_	_	_	_
13	during	during	_	_	_	_	_	_	_
14	lymphocyte	lymphocyte	_	_	_	_	_	_	_
15	activation	activation	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	found	find	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	T	t	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	anti-CD3-induced	anti-cd3-induced	_	_	_	_	_	_	_
9	c-Rel	c-rel	_	_	_	_	_	_	_
10	expression	expression	_	_	_	_	_	_	_
11	was	be	_	_	_	_	_	_	_
12	blocked	block	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	PF	PF	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	whereas	whereas	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	induction	induction	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	other	other	_	_	_	_	_	_	_
21	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
22	family	family	_	_	_	_	_	_	_
23	members	member	_	_	_	_	_	_	_
24	was	be	_	_	_	_	_	_	_
25	not	not	_	_	_	_	_	_	_
26	significantly	significantly	_	_	_	_	_	_	_
27	affected	affect	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	induction	induction	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	NF-AT	NF-AT	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	which	which	_	_	_	_	_	_	_
8	has	have	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	same	same	_	_	_	_	_	_	_
11	signaling	signaling	_	_	_	_	_	_	_
12	requirements	requirement	_	_	_	_	_	_	_
13	as	as	_	_	_	_	_	_	_
14	c-Rel	c-rel	_	_	_	_	_	_	_
15	induction	induction	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	was	be	_	_	_	_	_	_	_
18	not	not	_	_	_	_	_	_	_
19	inhibited	inhibit	_	_	_	_	_	_	_
20	by	by	_	_	_	_	_	_	_
21	PF	PF	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Among	among	_	_	_	_	_	_	_
2	genes	gene	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	respond	respond	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	these	these	_	_	_	_	_	_	_
7	transcription	transcription	_	_	_	_	_	_	_
8	factors	factor	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	IL-2	il-2	_	_	_	_	_	_	_
11	mRNA	mrna	_	_	_	_	_	_	_
12	induction	induction	_	_	_	_	_	_	_
13	was	be	_	_	_	_	_	_	_
14	suppressed	suppress	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	PF	PF	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	whereas	whereas	_	_	_	_	_	_	_
19	IL-2R(alpha)	il-2r(alpha)	_	_	_	_	_	_	_
20	chain	chain	_	_	_	_	_	_	_
21	mRNA	mrna	_	_	_	_	_	_	_
22	induction	induction	_	_	_	_	_	_	_
23	was	be	_	_	_	_	_	_	_
24	not	not	_	_	_	_	_	_	_
25	affected	affect	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	observations	observation	_	_	_	_	_	_	_
3	implicated	implicate	_	_	_	_	_	_	_
4	c-Rel	c-rel	_	_	_	_	_	_	_
5	as	as	_	_	_	_	_	_	_
6	an	an	_	_	_	_	_	_	_
7	IL-2	il-2	_	_	_	_	_	_	_
8	promoter	promoter	_	_	_	_	_	_	_
9	factor	factor	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	for	for	_	_	_	_	_	_	_
12	which	which	_	_	_	_	_	_	_
13	experimental	experimental	_	_	_	_	_	_	_
14	support	support	_	_	_	_	_	_	_
15	was	be	_	_	_	_	_	_	_
16	obtained	obtain	_	_	_	_	_	_	_
17	from	from	_	_	_	_	_	_	_
18	transient	transient	_	_	_	_	_	_	_
19	transfection	transfection	_	_	_	_	_	_	_
20	experiments	experiment	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	with	with	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	observation	observation	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	T	t	_	_	_	_	_	_	_
8	cells	cell	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	c-Rel	c-rel	_	_	_	_	_	_	_
11	induction	induction	_	_	_	_	_	_	_
12	was	be	_	_	_	_	_	_	_
13	not	not	_	_	_	_	_	_	_
14	blocked	block	_	_	_	_	_	_	_
15	by	by	_	_	_	_	_	_	_
16	PF	PF	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	B	B	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	greater	great	_	_	_	_	_	_	_
3	selectivity	selectivity	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	PF	PF	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	compared	compare	_	_	_	_	_	_	_
8	with	with	_	_	_	_	_	_	_
9	FK506	FK506	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	at	at	_	_	_	_	_	_	_
12	both	both	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	molecular	molecular	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	cellular	cellular	_	_	_	_	_	_	_
17	levels	level	_	_	_	_	_	_	_
18	may	may	_	_	_	_	_	_	_
19	prove	prove	_	_	_	_	_	_	_
20	advantageous	advantageous	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	manipulating	manipulate	_	_	_	_	_	_	_
23	T	t	_	_	_	_	_	_	_
24	cell	cell	_	_	_	_	_	_	_
25	responses	response	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	vivo	vivo	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

